Human EDARADD activation kit by CRISPRa

CAT#: GA115025

EDARADD CRISPRa kit - CRISPR gene activation of human EDAR associated death domain



  See Other Versions

CNY 12255.00


货期*
4周

规格
    • 1 kit

Product images

推荐一起购买 (3)
EDARADD rabbit polyclonal antibody
    • 100 ul

CNY 1999.00
CNY 3280.00


EDARADD (Myc-DDK-tagged)-Human EDAR-associated death domain (EDARADD), transcript variant B
    • 10 ug

CNY 2400.00
CNY 3990.00


EDARADD Rabbit polyclonal Antibody
    • 100 ul

CNY 1999.00
CNY 3280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol EDARADD
Locus ID 128178
Kit Components

GA115025G1, EDARADD gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA115025G2, EDARADD gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA115025G3, EDARADD gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Reference Data
RefSeq NM_080738, NM_145861
Synonyms ECTD11A; ECTD11B; ED3; EDA3
Summary This gene was identified by its association with ectodermal dysplasia, a genetic disorder characterized by defective development of hair, teeth, and eccrine sweat glands. The protein encoded by this gene is a death domain-containing protein, and is found to interact with EDAR, a death domain receptor known to be required for the development of hair, teeth and other ectodermal derivatives. This protein and EDAR are coexpressed in epithelial cells during the formation of hair follicles and teeth. Through its interaction with EDAR, this protein acts as an adaptor, and links the receptor to downstream signaling pathways. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...